Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
BMC Cancer|November 3, 2019
Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancerF Bazan, E Dobi, B Royer, et al.
Breast (Edinburgh, Scotland)|August 10, 2010
Sequential taxane and anthracycline-containing neoadjuvant regimens: the sequential order impactA Thiery-Vuillemin, A Llombart-Cussac, L Chaigneau, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2004
Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancerE Guardiola, F Peyrade, L Chaigneau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2013
Correlation between overall survival and growth modulation index in pre-treated sarcoma patients: a study from the French Sarcoma GroupS Cousin, J Y Blay, F Bertucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2011
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcomeN Penel, A Italiano, I Ray-Coquard, et al.
European Journal of Cancer (Oxford, England : 1990)|February 10, 2012
Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trialM Gross-Goupil, A Fourcade, E Blot, et al.
BMC Cancer|October 17, 2015
Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma GroupJ Khalifa, M Ouali, L Chaltiel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2013
Advanced chondrosarcomas: role of chemotherapy and survivalA Italiano, O Mir, A Cioffi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 10, 2025
Regorafenib as maintenance therapy after first-line doxorubicin-based chemotherapy in advanced non-adipocytic soft tissue sarcomas patients: a double-blind randomised trialN Penel, A Italiano, J Wallet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2014
Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: a randomized controlled open-label trialA Adenis, J-Y Blay, B Bui-Nguyen, et al.
Pageof 3